Satellos Bioscience Stock Performance
| MSCL Stock | 15.99 0.52 3.36% |
Satellos Bioscience holds a performance score of 19 on a scale of zero to a hundred. The entity has a beta of -0.18, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Satellos Bioscience are expected to decrease at a much lower rate. During the bear market, Satellos Bioscience is likely to outperform the market. Use Satellos Bioscience maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to analyze future returns on Satellos Bioscience.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Satellos Bioscience are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Satellos Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:12 | Last Split Date 2026-01-30 |
1 | Will Satellos Bioscience Inc. stock benefit from commodity supercycle - Earnings Performance Report Growth-Oriented Investment Plans - newser.com | 11/19/2025 |
2 | Satellos to join Piper Sandler, Oppenheimer investor events in December - Stock Titan | 11/25/2025 |
3 | Market Dynamics and Trading Signals - news.stocktradersdaily.com | 12/16/2025 |
4 | Will Satellos Bioscience Inc. stock outperform benchmarks - 2026 world cup usa national team quarterfinals top scorers possession football match prediction expe... | 01/06/2026 |
5 | Long Term Trading Analysis for - Stock Traders Daily | 01/14/2026 |
| Begin Period Cash Flow | 22.1 M | |
| Total Cashflows From Investing Activities | 6.3 M |
Satellos |
Satellos Bioscience Relative Risk vs. Return Landscape
If you would invest 840.00 in Satellos Bioscience on November 5, 2025 and sell it today you would earn a total of 759.00 from holding Satellos Bioscience or generate 90.36% return on investment over 90 days. Satellos Bioscience is generating 1.1743% of daily returns and assumes 4.8626% volatility on return distribution over the 90 days horizon. Simply put, 43% of stocks are less volatile than Satellos, and 77% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Satellos Bioscience Target Price Odds to finish over Current Price
The tendency of Satellos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 15.99 | 90 days | 15.99 | near 1 |
Based on a normal probability distribution, the odds of Satellos Bioscience to move above the current price in 90 days from now is near 1 (This Satellos Bioscience probability density function shows the probability of Satellos Stock to fall within a particular range of prices over 90 days) .
Satellos Bioscience Price Density |
| Price |
Predictive Modules for Satellos Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Satellos Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Satellos Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Satellos Bioscience is not an exception. The market had few large corrections towards the Satellos Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Satellos Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Satellos Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.95 | |
β | Beta against Dow Jones | -0.18 | |
σ | Overall volatility | 2.22 | |
Ir | Information ratio | 0.18 |
Satellos Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Satellos Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Satellos Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Satellos Bioscience appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (28.1 M) with loss before overhead, payroll, taxes, and interest of (16.68 M). | |
| Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations. |
Satellos Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Satellos Stock often depends not only on the future outlook of the current and potential Satellos Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Satellos Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.6 M | |
| Cash And Short Term Investments | 69.9 M |
Satellos Bioscience Fundamentals Growth
Satellos Stock prices reflect investors' perceptions of the future prospects and financial health of Satellos Bioscience, and Satellos Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Satellos Stock performance.
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.54 | ||||
| Current Valuation | 186.87 M | ||||
| Shares Outstanding | 15.46 M | ||||
| Price To Book | 5.06 X | ||||
| Gross Profit | (16.68 M) | ||||
| EBITDA | (28.08 M) | ||||
| Net Income | (28.1 M) | ||||
| Cash And Equivalents | 40.07 M | ||||
| Total Debt | 5.16 M | ||||
| Book Value Per Share | 2.98 X | ||||
| Cash Flow From Operations | (24.98 M) | ||||
| Earnings Per Share | 3.48 X | ||||
| Market Capitalization | 239.15 M | ||||
| Total Asset | 73.02 M | ||||
| Retained Earnings | (75.6 M) | ||||
About Satellos Bioscience Performance
By examining Satellos Bioscience's fundamental ratios, stakeholders can obtain critical insights into Satellos Bioscience's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Satellos Bioscience is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (5.70) | (5.99) | |
| Return On Capital Employed | (2.25) | (2.36) | |
| Return On Assets | (2.10) | (2.21) | |
| Return On Equity | (3.87) | (3.67) |
Things to note about Satellos Bioscience performance evaluation
Checking the ongoing alerts about Satellos Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Satellos Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Satellos Bioscience appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (28.1 M) with loss before overhead, payroll, taxes, and interest of (16.68 M). | |
| Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations. |
- Analyzing Satellos Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Satellos Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Satellos Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Satellos Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Satellos Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Satellos Bioscience's stock. These opinions can provide insight into Satellos Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.